Another case-control study mentioned that C3 serum levels were higher in NAFLD patients [13] and one cross-sectional study concluded that C3a levels paralleled the degree of liver injury [14]. This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.